PURPLE BIOTECH LTD-ADR (PPBT) Fundamental Analysis & Valuation

NASDAQ:PPBT • US74638P1093

Current stock price

3.7888 USD
-0.02 (-0.56%)
Last:

This PPBT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. PPBT Profitability Analysis

1.1 Basic Checks

  • In the past year PPBT has reported negative net income.
  • PPBT had a negative operating cash flow in the past year.
  • PPBT had negative earnings in each of the past 5 years.
  • PPBT had a negative operating cash flow in each of the past 5 years.
PPBT Yearly Net Income VS EBIT VS OCF VS FCFPPBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

  • PPBT has a Return On Assets of -8.32%. This is in the better half of the industry: PPBT outperforms 70.83% of its industry peers.
  • PPBT has a better Return On Equity (-9.92%) than 73.96% of its industry peers.
Industry RankSector Rank
ROA -8.32%
ROE -9.92%
ROIC N/A
ROA(3y)-34.7%
ROA(5y)-32.74%
ROE(3y)-42.11%
ROE(5y)-37.99%
ROIC(3y)N/A
ROIC(5y)N/A
PPBT Yearly ROA, ROE, ROICPPBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • PPBT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PPBT Yearly Profit, Operating, Gross MarginsPPBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2K -4K -6K -8K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. PPBT Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for PPBT has been increased compared to 1 year ago.
  • PPBT has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, PPBT has an improved debt to assets ratio.
PPBT Yearly Shares OutstandingPPBT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
PPBT Yearly Total Debt VS Total AssetsPPBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of -1.26, we must say that PPBT is in the distress zone and has some risk of bankruptcy.
  • PPBT has a Altman-Z score (-1.26) which is comparable to the rest of the industry.
  • PPBT has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.00, PPBT is doing good in the industry, outperforming 61.46% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.26
ROIC/WACCN/A
WACCN/A
PPBT Yearly LT Debt VS Equity VS FCFPPBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 1.78 indicates that PPBT should not have too much problems paying its short term obligations.
  • The Current ratio of PPBT (1.78) is worse than 65.10% of its industry peers.
  • A Quick Ratio of 1.78 indicates that PPBT should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.78, PPBT perfoms like the industry average, outperforming 42.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.78
PPBT Yearly Current Assets VS Current LiabilitesPPBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. PPBT Growth Analysis

3.1 Past

  • PPBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 85.67%, which is quite impressive.
EPS 1Y (TTM)85.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PPBT Yearly Revenue VS EstimatesPPBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 200K 400K 600K 800K

More info and screens

Find the best growth stocksShow best growing peers

0

4. PPBT Valuation Analysis

4.1 Price/Earnings Ratio

  • PPBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PPBT Price Earnings VS Forward Price EarningsPPBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PPBT Per share dataPPBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PPBT Dividend Analysis

5.1 Amount

  • PPBT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PPBT Fundamentals: All Metrics, Ratios and Statistics

PURPLE BIOTECH LTD-ADR

NASDAQ:PPBT (3/19/2026, 8:23:50 PM)

3.7888

-0.02 (-0.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-03
Earnings (Next)05-19
Inst OwnersN/A
Inst Owner Change488.74%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap34.21M
Revenue(TTM)N/A
Net Income(TTM)-3.25M
Analysts0
Price TargetN/A
Short Float %N/A
Short Ratio0.89
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.04
P/tB 6.94
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.73
FCFYN/A
OCF(TTM)-0.73
OCFYN/A
SpS0
BVpS3.63
TBVpS0.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.32%
ROE -9.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-34.7%
ROA(5y)-32.74%
ROE(3y)-42.11%
ROE(5y)-37.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.78
Altman-Z -1.26
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)38.32%
Cap/Depr(5y)46.22%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y68.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y65.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.53%
OCF growth 3YN/A
OCF growth 5YN/A

PURPLE BIOTECH LTD-ADR / PPBT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PURPLE BIOTECH LTD-ADR?

ChartMill assigns a fundamental rating of 1 / 10 to PPBT.


What is the valuation status of PURPLE BIOTECH LTD-ADR (PPBT) stock?

ChartMill assigns a valuation rating of 0 / 10 to PURPLE BIOTECH LTD-ADR (PPBT). This can be considered as Overvalued.


How profitable is PURPLE BIOTECH LTD-ADR (PPBT) stock?

PURPLE BIOTECH LTD-ADR (PPBT) has a profitability rating of 1 / 10.


Can you provide the financial health for PPBT stock?

The financial health rating of PURPLE BIOTECH LTD-ADR (PPBT) is 3 / 10.